Previous close | 1.9400 |
Open | 1.9400 |
Bid | 1.5000 |
Ask | 4.3000 |
Strike | 110.00 |
Expiry date | 2024-01-19 |
Day's range | 1.9400 - 1.9400 |
Contract range | N/A |
Volume | |
Open interest | 117 |
HOLX vs. EW: Which Stock Is the Better Value Option?
Results from Abbott's (ABT) PORTICO study support Navitor's recent FDA approval to treat patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.
Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.